Spectroscopy in prostate cancer: hope or hype?

Area of Science:

• Oncology
• Medical Imaging
• Biochemistry

Background:

• Clinical applications of image-based radiation therapy for prostate cancer are expanding.
• Magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) are emerging as powerful tools for prostate cancer research.

Purpose of the Study:

• To evaluate the utility of combined MRI/MRSI for noninvasively studying prostate cancer cellular metabolism and anatomy.
• To explore the potential of MRI/MRSI in defining tumor volume through functional or metabolic imaging.
• To assess the role of metabolic changes in understanding cancer aggressiveness and spread.

Main Methods:

• Utilizing combined magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) for prostate cancer assessment.
• Analyzing metabolic changes before and after therapy to understand cancer behavior.
• Integrating MRI findings with MRSI-derived metabolic abnormalities to evaluate cancer spread.

Main Results:

• The MRI/MRSI exam provides a unique noninvasive method to study prostate cellular metabolism and anatomy.
• This technology can define tumor volume using functional or metabolic imaging.
• Metabolic changes observed with MRI/MRSI correlate with cancer aggressiveness and can improve assessment of extracapsular extension.

Conclusions:

• Combined MRI/MRSI shows significant potential for improving the diagnosis, staging, and treatment planning of prostate cancer.
• Further studies are needed to fully elucidate the clinical benefits and challenges of this integrated imaging approach.